Evidence map›Paper›PMID 30366853›Full record

ArticleInternational journal of cardiology2019

Aortic arch tortuosity, a novel biomarker for thoracic aortic disease, is increased in adults with bicuspid aortic valve.

Bader Aldeen Alhafez, Van Thi Thanh Truong, Daniel Ocazionez, Sahand Sohrabi, Harleen Sandhu, Anthony Estrera, Hazim J Safi, Artur Evangelista, Lydia Dux-Santoy Hurtado, Andrea Guala and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development of idealized human aortic models forFrontiers in cardiovascular medicine · 2024
    Article
  11. Article
  12. Navigating the challenges of bicuspid aortic valve-aortopathy.Global cardiology science & practice · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Bader Aldeen AlhafezDepartment of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 1.150, Houston, TX 77030, USA.
Van Thi Thanh TruongCenter for Clinical Research and Evidence-Based Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 2.106, Houston, TX 77030, USA.
Daniel OcazionezDepartment of Diagnostic and Interventional Imaging, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, 2.130B, Houston, TX 77030, USA.
Sahand SohrabiDepartment of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 1.150, Houston, TX 77030, USA.
Harleen SandhuDepartment of Cardiothoracic and Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, 6400 Fannin Street, Suite 2850, Houston, TX 77030, USA.
Anthony EstreraDepartment of Cardiothoracic and Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, 6400 Fannin Street, Suite 2850, Houston, TX 77030, USA.
Hazim J SafiDepartment of Cardiothoracic and Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, 6400 Fannin Street, Suite 2850, Houston, TX 77030, USA.
Artur EvangelistaDepartment of Cardiology, Vall d'Hebron University Hospital, CIBER-CV, Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona, Spain.
Lydia Dux-Santoy HurtadoDepartment of Cardiology, Vall d'Hebron University Hospital, CIBER-CV, Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona, Spain.
Andrea GualaDepartment of Cardiology, Vall d'Hebron University Hospital, CIBER-CV, Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona, Spain.
Siddharth K PrakashDepartment of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 1.150, Houston, TX 77030, USA. Electronic address: Siddharth.K.Prakash@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USCentro de Investigación en Red en Enfermedades Cardiovasculares · ESCenter for Clinical Research (United States) · USThe University of Texas Health Science Center · US

Funding

Genetic Basis of Early Onset Bicuspid Aortic Valve DiseaseR01HL137028 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI PRAKASH, SIDDHARTH KUMAR · 2017 to 2020
$1.5M
NHLBI NIH HHS R01 HL137028
6 · The paper itself

Abstract

introductionArterial tortuosity has emerged as a predictor of adverse outcomes in congenital aortopathies using 3D reconstructed images. We validated a new method to estimate aortic arch tortuosity on 2D CT. We hypothesize that arch tortuosity may identify bicuspid aortic valve (BAV) patients at high risk to develop thoracic aortic aneurysms or aortic dissections (TAD).

methodsBAV subjects with chest CT scans were retrospectively identified in our clinical records and matched to tricuspid aortic valve (TAV) controls by age, gender, and presentation with TAD. Subjects with prior ascending aortic intervention were excluded. Measurements included aortic arch tortuosity, length, angle, width and height. Total aortic tortuosity was estimated in subjects with available abdominal images.

results120 BAV and 234 TAV subjects were included. Our 2D measurements were highly correlated with 3D midline arch measurements and had high inter- and intra-observer reliability. Compared to TAV, BAV subjects had increased arch tortuosity (median 1.76 [Q1-Q3: 1.62-1.95] vs. 1.63 [1.53-1.78], P < 0.01), length (149 [136-160] vs. 135 [122-152] mm, P < 0.01), height (46 [41-53] vs. 39 [34-47] mm, P < 0.01), and vertex acuity (70 [61-77] vs. 75 [68-81] degree, P < 0.01). In a multivariable analysis, arch tortuosity remained independently associated with BAV after adjusting for aortic diameter and other clinical characteristics.

conclusionsWe found that aortic arch tortuosity is significantly increased in BAV and may identify BAV patients who are at increased risk for TAD. Further studies to evaluate the association between tortuosity and clinical outcomes are in progress.

Indexed as

Aorta, ThoracicAortic DiseasesAortic ValveBicuspid Aortic Valve DiseaseEchocardiographyFemaleHeart Valve DiseasesHumansImaging, Three-DimensionalIncidenceMaleMiddle AgedTomography, X-Ray ComputedUnited StatesBicuspid aortic valveThoracic aortic aneurysmThoracic aortic dissectionTortuosity

Identifiers

PMID30366853
PMCPMC6436988
OpenAlexW2895798744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.